Stephens restated their overweight rating on shares of The Pennant Group (NASDAQ:PNTG – Free Report) in a research note released on Tuesday morning,Benzinga reports. They currently have a $38.00 target price on the stock.
Several other equities analysts have also recently weighed in on PNTG. Wells Fargo & Company assumed coverage on The Pennant Group in a report on Thursday, December 19th. They set an “equal weight” rating and a $33.00 price target on the stock. Truist Financial lowered their target price on The Pennant Group from $32.00 to $28.00 and set a “hold” rating on the stock in a report on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $34.80.
Get Our Latest Stock Report on The Pennant Group
The Pennant Group Stock Up 1.9 %
Institutional Investors Weigh In On The Pennant Group
Hedge funds have recently modified their holdings of the business. Mackenzie Financial Corp purchased a new position in The Pennant Group during the fourth quarter valued at $475,000. PharVision Advisers LLC purchased a new position in The Pennant Group during the fourth quarter valued at approximately $304,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of The Pennant Group by 22.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 77,885 shares of the company’s stock worth $2,066,000 after purchasing an additional 14,020 shares during the period. Voloridge Investment Management LLC bought a new position in shares of The Pennant Group in the fourth quarter worth approximately $1,282,000. Finally, Zimmer Partners LP purchased a new stake in shares of The Pennant Group in the fourth quarter worth $3,978,000. Institutional investors own 85.88% of the company’s stock.
The Pennant Group Company Profile
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Further Reading
- Five stocks we like better than The Pennant Group
- 3 Healthcare Dividend Stocks to Buy
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Dividend Capture Strategy: What You Need to Know
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Stock Market Upgrades: What Are They?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.